NAGLAZYME conc perf 5 mg/5ml flac 5 ml
7680582240013
CH-58224
A16AB08
07.14.0.
1 / 3
google
Details
- Product number
- 5822401
- CPT
- -
- Packaging group
- 1 x 5 ml
- Unit
- Durchstechflasche(n)
- Composition
- galsulfasum 5 mg, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, polysorbatum 80, aqua ad iniectabile q.s., ad solutionem pro 5 ml corresp. natrium 18.4 mg.
Articles (1)
Naglazyme, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1 x 5 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
18.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1462.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2025
Authorization holder
DRAC AG
3280 Murten
Authorization information
- Swissmedic authorization number
- 58224
- Drug name
- Naglazyme, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- A16AB08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/10/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NAGLAZYME conc perf 5 mg/5ml flac 5 ml
- Description (DE)
- NAGLAZYME Inf Konz 5 mg/5ml Durchstf 5 ml
- Market launch
- 02/10/2007
- Narcotic (BTM)
- No